Growth Metrics

Apyx Medical (APYX) Non-Current Assets (2016 - 2026)

Apyx Medical filings provide 16 years of Non-Current Assets readings, the most recent being $6.6 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 1.8% to $6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.6 million, a 1.8% decrease, with the full-year FY2025 number at $6.6 million, down 1.8% from a year prior.
  • Non-Current Assets hit $6.6 million in Q4 2025 for Apyx Medical, down from $6.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.5 million in Q2 2023 to a low of $4.1 million in Q1 2023.
  • Median Non-Current Assets over the past 5 years was $8.0 million (2021), compared with a mean of $7.8 million.
  • Biggest five-year swings in Non-Current Assets: plummeted 49.91% in 2023 and later skyrocketed 114.27% in 2024.
  • Apyx Medical's Non-Current Assets stood at $8.0 million in 2021, then grew by 10.26% to $8.8 million in 2022, then dropped by 18.82% to $7.1 million in 2023, then dropped by 5.71% to $6.7 million in 2024, then fell by 1.8% to $6.6 million in 2025.
  • The last three reported values for Non-Current Assets were $6.6 million (Q4 2025), $6.8 million (Q3 2025), and $6.6 million (Q2 2025) per Business Quant data.